Correlation Between Syndax Pharmaceuticals and Alector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Alector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Alector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Alector, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Alector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Alector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Alector.

Diversification Opportunities for Syndax Pharmaceuticals and Alector

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Syndax and Alector is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Alector in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alector and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Alector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alector has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Alector go up and down completely randomly.

Pair Corralation between Syndax Pharmaceuticals and Alector

Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 0.73 times more return on investment than Alector. However, Syndax Pharmaceuticals is 1.37 times less risky than Alector. It trades about 0.05 of its potential returns per unit of risk. Alector is currently generating about -0.19 per unit of risk. If you would invest  1,369  in Syndax Pharmaceuticals on December 5, 2024 and sell it today you would earn a total of  58.50  from holding Syndax Pharmaceuticals or generate 4.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy97.5%
ValuesDaily Returns

Syndax Pharmaceuticals  vs.  Alector

 Performance 
       Timeline  
Syndax Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Syndax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Alector 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Alector has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Syndax Pharmaceuticals and Alector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Syndax Pharmaceuticals and Alector

The main advantage of trading using opposite Syndax Pharmaceuticals and Alector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Alector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alector will offset losses from the drop in Alector's long position.
The idea behind Syndax Pharmaceuticals and Alector pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated